Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
clinical trials
fda
ipo
life sciences
national blog main
new york blog main
2
×
new york top stories
sanofi
2
×
takeda pharmaceutical
abbvie
agios pharmaceuticals
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
biogen
bluerock therapeutics
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer drugs
cancer immunotherapy
cerovene
covid-19
crispr
david e. shaw
deals
deerfield management
detroit blog main
detroit top stories
drug discovery
durvalumab
editas medicine
enasidenib
What
ipo
2
×
medicines
acquisitions
announced
bio
ceo
collabs
company’s
course
covid
daniel
deal
development
discover
experimental
gilead
gilead’s
growing
handiwork
help
helped
internal
introduce
landscape
month
o’day
pipeline
plans
roundup
scan
schrödinger
schrödinger’s
sciences
sets
software
spot
support
today
transformative
years
Language
unset
Current search:
sanofi
×
ipo
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline